Leaders in Ion Channel Biology
Leaders in Ion Channel Biology
Welcome to Metrion Biosciences
Metrion Biosciences is a UK-based Contract Research Organization (CRO) focussed on delivering a range of high quality ion channel drug discovery services. We provide highly skilled electrophysiology screening services to support client medicinal chemistry optimisation programmes, CiPA compliant cardiac safety profiling assays, neuroscience assays and translational assays. Working closely with our collaborators Assay.Works and Concept Life Sciences we also offer an expert integrated drug discovery service.
Metrion offers flexible business models according to the scope of each programme, with both fee-for-service and collaborative options available.
Our Expertise
Metrion has assembled a team of highly expert and dedicated ion channel specialists to support diverse ion channel drug discovery projects and modern safety assessment research. We combine in depth target class knowledge and high quality screening assays with experienced and collaborative project managers to keep your research focused upon meeting both objectives and timelines.
Our Facilities
Metrion is located within the Cambridge bio cluster, one of Europe’s largest bioscience research hubs. Our state of the art laboratories at Granta Park house high quality facilities for native and engineered cell line and induced pluripotent stem cell culture, a comprehensive suite of automated patch clamp platforms, multiple manual patch clamp rigs, fluorescence-based screening capability and laboratory data management and reporting systems.
Latest News
Metrion Biosciences announce collaboration with LifeArc
LifeArc and Metrion Biosciences extend partnership agreement to support LifeArc's neuroscience small molecule drug discovery programme. Metrion to provide assay [...]
Metrion Biosciences to attend SPS Berlin, 24-27 September 2017
Metrion Biosciences will be attending the Safety Pharmacology Society meeting in Berlin, 24-27 September 2017. John Ridley will be on [...]
Q2 2017 review
Q2 2017 was another productive quarter for the Metrion Biosciences team. Our stand-alone CRO sales continued on an upward trajectory, [...]